Innate: Lacutamab Treatment Program Moves Forward With Potential Expansion
Innate Pharma's Sezary Syndrome treatment shows strong results. Learn why IPHA stock offers potential with phase 2 data and ...
Pharmabiz4d
US FDA grants breakthrough therapy designation to Innate Pharma’s lacutamab for relapsed or refractory Sézary syndrome
US FDA grants breakthrough therapy designation to Innate Pharma’s lacutamab for relapsed or refractory Sézary syndrome: Marseille, France Tuesday, February 18, 2025, 12:00 Hrs ...
Innate’s lacutamab gains FDA breakthrough therapy designation
Innate Pharma has secured US Food and Drug Administration (FDA) breakthrough therapy designation for lacutamab to treat ...
Le Lézard5d
Innate Pharma Announces U.S. FDA Granted Breakthrough Therapy Designation to Lacutamab for Relapsed or Refractory Sézary Syndrome
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to ...
Oncology Nurse Advisor9d
CD70-Directed CAR-T Therapy Shows Promise in T-Cell Lymphoma
Researchers sought to determine whether the CAR-T therapy volamcabtagene durzigedleucel (CTX130) would be effective in patients with T-cell lymphoma.
Hosted on MSN12d
What Cancer Can Cause Itchy Skin?
The most common type of cutaneous T-cell lymphoma is called mycosis fungoides. A less common form, Sezary syndrome, can lead to a condition called erythroderma—a severe skin condition that can cause ...
Medscape14d
Treatment of Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Acitretin (Soriatane ®) and bexarotene are the two orally available retinoids used most commonly for treating MF. These drugs are derivatives of vitamin A and are in the same class of agents as ...
LinkedIn15d
Anand Urhekar’s Post
I see different types of patients in the clinic, Mycosis fungoides is on the rise, I have sucessfully treated many patients of Mycosis fungoides, however recurrences are common, you need to ...
aad.org15d
Cutaneous T-cell lymphoma: Diagnosis & treatment
Each infusion takes about 1 hour. Brand name: Lymphir Mogamulizumab-kpkc is FDA approved to treat adults who have tried at least one other treatment for mycosis fungoides or Sézary syndrome, only to ...
BioSpace16d
Mycosis Fungoides Market Expected to Grow at a CAGR Of 5.1% During 2025-2035, Impelled by Advancements in Innovative Therapies
Mycosis Fungoides Market Outlook 2025-2035: The mycosis fungoides market is demonstrating a promising trajectory, with a projected CAGR of 5.1% across the 7 major markets between 2025 and 2035. The ...
Original paper19d
Psychosocial burden of patients with mycosis fungoides and Sézary syndrome compared to other dermatological patients. Pilot study
Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneous Lymphomas. Blood 2000; 95: 2212-8. 3. Olsen EA, Rook AH, Zic J, et al.
Original paper23d
Psychosocial burden of patients with mycosis fungoides and Sézary syndrome compared to other dermatological patients. Pilot study
University Centre of General Dermatology and Oncodermatology, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland Faculty of Medicine, Wroclaw University of Science and Technology, ...